Burkholderia cepacia genomovar III and Burkholderia vietnamiensis double infection in a cystic fibrosis child.
Herein we report a case of a cystic fibrosis child who was simultaneously infected with Burkholderia cepacia genomovar III and Burkholderia vietnamiensis. After antimicrobial therapy only B. cepacia genomovar III persisted.
Federal University of Pernambuco, Recife, Brazil.
Marcelo
M
Magalhães
Murilo C A
MC
de Britto
Peter
P
Vandamme
D000583:Amikacin / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D019117:Burkholderia / Q000235:genetics / Q000302:isolation & purification*; D019121:Burkholderia Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology*; D042602:Burkholderia cepacia complex / Q000235:genetics / Q000302:isolation & purification; D002939:Ciprofloxacin / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications* / Q000382:microbiology*; D024881:Drug Resistance, Bacterial / Q000235:genetics; D006801:Humans; D007223:Infant; D008297:Male; D012141:Respiratory Tract Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology*; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000583:Amikacin